Lipid‐lowering therapy of everolimus‐related severe hypertriglyceridaemia in a pancreatic neuroendocrine tumour (pNET)

E-ISSN： 1365-2710|43|1|114-116

ISSN： 0269-4727

Source： JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol.43, Iss.1, 2018-02, pp. : 114-116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prolonged Clinical Benefit of Everolimus Therapy in the Management of High-Grade Pancreatic Neuroendocrine Carcinoma

Case Reports in Oncology, Vol. 6, Iss. 2, 2013-08 ,pp. : 441-449

Karger

Access to resources Recommend Favorite

Beyond lipid-lowering therapy: does ezetimibe enhance the effects of statins on atherosclerosis?

By Krishnamoorthy Suresh Lip Gregory YH

Therapy, Vol. 5, Iss. 4, 2008-07 ,pp. : 487-489

Future Medicine

Access to resources Recommend Favorite

Pioglitazone boosts conventional lipid-lowering therapy for familial combined hyperlipidemia

Future Lipidology, Vol. 2, Iss. 3, 2007-06 ,pp. : 259-261

Future Medicine

Access to resources Recommend Favorite

Meta-Analysis of Lipid-Lowering Therapy in Maintenance Dialysis Patients

Nephron Clin Pract, Vol. 124, Iss. 3-4, 2014-01 ,pp. : 209-217

Karger

Access to resources Recommend Favorite

Seasonal Variation of Lipid-Lowering Effects of Complex Spa Therapy

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 10, Iss. 2, 2003-05 ,pp. : 78-84

Karger

Access to resources Recommend Favorite